4ES-21407-08939
4 vaccinations
7 coded responses
35 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 462 / IN
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Pfizer-BioNTech
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-29
-
2021-02-04
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-04
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Poor quality sleep — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tirednessFree text: Restless sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
-
2021-02-18
Survey response — day 14, dose 2MedDRA: Headache, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: cold-like symptoms: runny/stuffy nose, mild headache, sore throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
-
2021-08-07
Survey response — 6 months, dose 2MedDRA: Diarrhoea, Fatigue, Nausea, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, fatigue, nausea, diarrheaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-10
Dose 3 — Pfizer-BioNTech
- 2022-02-04
-
2022-05-11
Survey response — 6 months, dose 3MedDRA: Cough, Nasal congestion, Nasopharyngitis, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold symptoms (runny/congested nose, minor cough)MedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Dose 4 — Pfizer-BioNTech
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-14
- 2022-10-23
- 2022-11-13
-
2022-11-18
Survey response — day 42, dose 4MedDRA: Cough, Fatigue, Influenza, Panic disorder, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Flu A, congestion, coughing, fatigue, runny nose, panic symptomsMedDRA releases: 2024-11 · check-in free text available
-
2023-01-06
Survey response — 3 months, dose 4MedDRA: Diarrhoea, Influenza, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-04-12
Survey response — 6 months, dose 4MedDRA: Nasopharyngitis, Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-12
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-04 | Pfizer-BioNTech | |
| 3 | 2021-11-10 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-12 | Unsuccessful |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Restless sleep
Release 4 — day 14, dose 2
Symptoms: cold-like symptoms: runny/stuffy nose, mild headache, sore throat
Release 9 — 6 months, dose 2
Symptoms: Congestion, fatigue, nausea, diarrhea
Release 11 — 6 months, dose 3
Symptoms: Cold symptoms (runny/congested nose, minor cough)
Release 12 — day 42, dose 4
Symptoms: Flu A, congestion, coughing, fatigue, runny nose, panic symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Panic disorder | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Poor quality sleep | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release